PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 62 trials

Enrolling now

Nationwide

A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

University of Rochester

Ph 2·~8yr·1 site in NY

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Edgewood Oncology Inc.

Ph 1·~7yr·3 sites in CA, NY, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Haploidentical Transplant Trial

University of Wisconsin, Madison

Procedure·Ph 1·~12yr·1 site in WI

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Azacitidine and Quizartinib for Blood Cancer

M.D. Anderson Cancer Center

Ph 1/2·~7yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Cladribine, Idarubicin, Cytarabine, and Quizartinib Trial

M.D. Anderson Cancer Center

Ph 1/2·~8yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Cladribine, Idarubicin, Cytarabine, and Venetoclax Trial

M.D. Anderson Cancer Center

Ph 2·~16yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Fred Hutchinson Cancer Center

Procedure·Ph 2·~8yr·1 site in WA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

CPX-351 and Ivosidenib for Leukemia Treatment

M.D. Anderson Cancer Center

Ph 2·~5yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Curcumin Trial for Inflammation

University of Southern California

Procedure·Ph 2·~3yr·2 sites in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Decitabine and Ruxolitinib for Myelofibrosis

University of Washington

Procedure·Ph 2·~7yr·1 site in WA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Dexrazoxane Hydrochloride to Prevent Heart Problems from Chemotherapy

M.D. Anderson Cancer Center

Ph 2·~9yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Edetate Calcium Disodium or Succimer for Leukemia Treatment

M.D. Anderson Cancer Center

Ph 1·~9yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

M.D. Anderson Cancer Center

Ph 2·~9yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

HA-1 T TCR T Cell Immunotherapy for Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Procedure·Ph 1·~10yr·1 site in WA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Ivosidenib, Venetoclax, and Azacitidine for Hematologic Malignancies

M.D. Anderson Cancer Center

Ph 1/2·~10yr·4 sites in MA, OH, OR +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

MYELOMATCH Screening Trial

National Cancer Institute (NCI)

Procedure·Ph 2·~5yr·335 sites in AL, AR, AZ +41

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Study to Find the Best Dose of CYAD-02 for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Celyad Oncology SA

Ph 1·~15yr·2 sites in FL, KS

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

National Cancer Institute (NCI)

Procedure·Ph 2·~1.5yr·137 sites in CA, FL, GA +26

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Cancer Connected Access and Remote Expertise Beyond Walls Program

Mayo Clinic

Ph 2·~12mo·1 site in FL

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Two Step Haplo With Radiation Conditioning

Thomas Jefferson University

Ph 2·~11yr·1 site in PA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Venetoclax in Combination with Busulfan for High-Risk AML/MDS

M.D. Anderson Cancer Center

Procedure·Ph 2/3·~6yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

At-Home Cancer Directed Therapy Versus in Clinic

Mayo Clinic

Procedure·Ph 2·~3yr·2 sites in FL, ND

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Fludarabine, Cytarabine, Filgrastim, Gemtuzumab Ozogamicin, and Idarubicin for Leukemia/Myelodysplastic Syndrome

M.D. Anderson Cancer Center

Ph 2·~22yr·1 site in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

City of Hope Medical Center

Procedure·Ph 1·~3yr·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify